Type of security: Stock
Sector: Health Care
Industry: Medical/Nursing Services
The data is delayed by 15 minutes.
AMED is in the long-term up 193% in 4 years.
Description: Amedisys, Inc., together with its subsidiaries, provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The Home Health segment offers a range of services in the homes of individuals who may be recovering from an illness, injury, or surgery. This segment provides skilled nurses, nurse practitioners, home health aides, physical and occupational therapists, speech therapists, and medical social services; and chronic care clinical programs for patients with chronic diseases, such as cardiovascular, respiratory, diabetes, behavioral health, rehabilitative, and medical surgical conditions. The Hospice segment offers care that is designed to provide comfort and support for those who are facing a terminal illness, including heart disease, pulmonary disease, dementia, Alzheimer?s, HIV/AIDS, or cancer. As of December 31, 2013, it owned and operated 367 Medicare-certified home health care centers, 97 Medicare-certified hospice care centers, and 1 hospice inpatient unit
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||Sales Growth - Q/Q||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||ROE||ROI|
|Current Ratio||Quick Ratio||Long Term Debt/Equity||Debt Ratio|
|Gross Margin||Operating Margin||Net Profit Margin||Dividend Payout Ratio|
|Cash From Financing Activities||-20.05 M||Cash From Investing Activities||-11.82 M||Cash From Operating Activities||57.04 M||Gross Profit||138.45 M|
|Net Profit||10.64 M||Operating Profit||15.53 M||Total Assets||645.43 M||Total Current Assets||168.37 M|
|Total Current Liabilities||176.03 M||Total Debt||95.52 M||Total Liabilities||266.09 M||Total Revenue||314.15 M|
|High 52 week||140.23||Low 52 week||93.44||Last close||135.63||Last change||-0.26%|
|RSI||69.41||Average true range||4.16||Beta||0.82||Volume||144.91 K|
|Simple moving average 20 days||3.02%||Simple moving average 50 days||9.35%||Simple moving average 200 days||10.91%|
|Performance Week||0.46%||Performance Month||10.27%||Performance Quart||17.12%||Performance Half||4.05%|
|Performance Year||23.07%||Performance Year-to-date||15.81%||Volatility daily||1.36%||Volatility weekly||3.05%|
|Volatility monthly||6.24%||Volatility yearly||21.63%||Relative Volume||270.73%||Average Volume||357.95 K|
|New High||New Low|
2019-11-13 16:30:00 | Amedisys to Present at the 2019 Jefferies London Healthcare Conference
2019-11-12 12:00:00 | nVoq and Amedisys Collaborate to Enhance the Clinician Experience
2019-11-11 09:30:00 | Amedisys Expanding Commitment to End-of-Life Care for Veterans
2019-11-11 08:52:01 | Is Amedisys AMED a Great Growth Stock?
2019-11-11 08:47:01 | 5 Stocks That Stand Out on Attractive Interest Coverage Ratio
2019-11-08 05:47:38 | A Close Look At Amedisys, Inc.’s NASDAQ:AMED 19% ROCE
2019-11-06 14:22:14 | Amedisys to Present at the 2019 Stephens Nashville Investment Conference
2019-11-05 12:00:00 | Media Statement from Amedisys Regarding CY 2020 Home Health Final Rule
2019-11-04 09:15:02 | Amedisys AMED Soars to 52-Week High, Time to Cash Out?
2019-11-01 14:32:52 | Amedisys Shares, Options Volume Pop
2019-10-31 12:17:04 | Amedisys AMED Q3 Earnings Beat Estimates, Revenues Meet
2019-10-31 11:09:03 | New Strong Buy Stocks for October 31st
2019-10-31 08:45:12 | Is Amedisys AMED a Solid Growth Stock? 3 Reasons to Think " Yes "
2019-10-31 07:49:11 | 5 Top Stocks to Gain From Fed's Stable Monetary Stance
2019-10-30 22:44:07 | Edited Transcript of AMED earnings conference call or presentation 30-Oct-19 3:00pm GMT
2019-10-29 17:35:09 | Amedisys AMED Beats Q3 Earnings and Revenue Estimates
2019-10-29 16:05:05 | Amedisys Reports Third Quarter 2019 Financial Results and Updates 2019 Guidance
2019-10-28 12:18:04 | Healthcare Stock Earnings Slated on Oct 29: HCA, MOH & More
2019-10-25 09:00:01 | Amedisys AMED Upgraded to Buy: Here's Why
2019-10-24 12:20:05 | Is Amedisys Inc AMED A Good Stock To Buy?
2019-10-24 10:42:31 | A Look At The Fair Value Of Amedisys, Inc. NASDAQ:AMED
2019-10-23 09:15:05 | Amedisys Announces Retirement of Donald A. Washburn and Welcomes Three New Directors
2019-10-22 09:55:01 | Add These 5 Stocks With Amazing Interest Coverage Ratio
2019-10-16 16:00:00 | Amedisys Announces Third Quarter Earnings Release and Conference Call Date
2019-10-09 17:10:09 | Medtronic Submits Two Pelvic Health Devices for FDA's PMA
2019-10-09 11:58:45 | WellSky's latest acquisition deepens its national reach
2019-10-09 11:22:03 | Omnicell Advances on Global Footing Despite Severe Rivalry
2019-10-08 07:00:00 | Amedisys Wins 18 Aster Awards for Home Health and Hospice Marketing
2019-10-08 06:34:31 | Is Amedisys NASDAQ:AMED A Risky Investment?
2019-10-07 10:10:02 | Will Amedisys AMED Beat Estimates Again in Its Next Earnings Report?
2019-10-03 11:27:03 | Tandem Diabetes' Inland Sales and Product Suite Are Tailwinds
2019-10-03 10:53:34 | SHP Honors 111 Amedisys Care Centers with SHPBest Awards
2019-10-01 11:56:03 | Illumina, Broad Institute Partner on Secondary Genomic Analysis
2019-09-30 10:06:02 | Medtronic MDT Gets FDA Nod to Study Intrepid TMVR System
2019-09-30 09:02:01 | Here's Why You Should Retain HMS Holdings HMSY Stock For Now
2019-09-27 10:08:02 | Haemonetics Grows on Strong Plasma, Hemostasis Management
2019-09-27 08:20:12 | Here's Why You Should Hold Zimmer Biomet ZBH Stock for Now
2019-09-26 10:57:02 | Here's Why You Should Hold GNC Holdings GNC Stock for Now
2019-09-26 10:00:02 | What Makes Amedisys AMED a Strong Momentum Stock: Buy Now?
2019-09-26 09:30:01 | Is Amedisys AMED Stock Outpacing Its Medical Peers This Year?
2019-09-25 11:26:03 | Cerner CERN Set to Improve Patient Experience With New Deal
2019-09-24 11:12:03 | Here's Why You Should Hold on to Wright Medical WMGI Stock
2019-09-23 11:25:03 | Illumina ILMN Gains on Product Pipeline, Global Footprint
2019-09-23 11:18:03 | Medtronic's MiniMed 670G Shows Favorable Outcome in Europe
2019-09-23 11:09:03 | Here's Why You Should Hold on to Nevro NVRO Stock for Now
2019-09-20 11:56:03 | QIAGEN QGEN Hurt by Low QuantiFERON-TB Sales & FX Headwind